Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Central Nervous System
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Alzheimer Disease - New Drugs, Markets and Companies
static version
printer friendly
pdf version
Alzheimer’s and Parkinson’s Disease - Global Strategic Business Report
static version
printer friendly
pdf version
Amyotrophic Lateral Sclerosis: A route to larger CNS markets?
static version
printer friendly
pdf version
Amyotrophic Lateral Sclerosis: A route to larger CNS markets?
static version
printer friendly
pdf version
Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application - 2 Volume Set
static version
printer friendly
pdf version
Arthritis in the United States
static version
printer friendly
pdf version
Autism: An Integrated View from Neurocognitive, Clinical and Intervention Research
static version
printer friendly
pdf version
^ Top
B
Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market
static version
printer friendly
pdf version
Blood-Brain Barriers: From Ontogeny to Artificial Interfaces, Two Volumes
static version
printer friendly
pdf version
Brain metastases
static version
printer friendly
pdf version
Building a Diabetes Medical Home: The Impact on Practice Work Flow, Patient Outcomes and Healthcare Costs, a 90-minute webinar on CD-ROM
static version
printer friendly
pdf version
^ Top
C
Central Nervous System - Alzheimer Disease Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Anxiety Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Dementia Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Depression Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Epilepsy Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Headache Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Migraine
static version
printer friendly
pdf version
Central Nervous System - Migraine Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Multiple Sclerosis Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Neuropathy Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Pain Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Parkinson Disease Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Schizophrenia Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Seizures Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System - Stroke Drug Pipeline Report
static version
printer friendly
pdf version
Central Nervous System Alzheimer Disease
static version
printer friendly
pdf version
Central Nervous System Anxiety
static version
printer friendly
pdf version
Central Nervous System Attention Deficit Disorder with Hyperactivity
static version
printer friendly
pdf version
Central Nervous System Dementia
static version
printer friendly
pdf version
Central Nervous System Depression
static version
printer friendly
pdf version
Central Nervous System Epilepsy
static version
printer friendly
pdf version
Central Nervous System Headache
static version
printer friendly
pdf version
Central Nervous System Insomnia or Sleep Disorders
static version
printer friendly
pdf version
Central Nervous System Memory Impairment
static version
printer friendly
pdf version
Central Nervous System Multiple Sclerosis
static version
printer friendly
pdf version
Central Nervous System Neuropathy
static version
printer friendly
pdf version
Central Nervous System Pain
static version
printer friendly
pdf version
Central Nervous System Parkinson Disease
static version
printer friendly
pdf version
Central Nervous System Psychotic Disorders
static version
printer friendly
pdf version
Central Nervous System Schizophrenia
static version
printer friendly
pdf version
Central Nervous System Seizures
static version
printer friendly
pdf version
Central Nervous System Stroke
static version
printer friendly
pdf version
Clinical Trials in Psychiatry, 2nd Edition
static version
printer friendly
pdf version
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Depression Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Multiple Sclerosis Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Neurodegenerative Disorders Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Schizophrenia (Chapter)
static version
printer friendly
pdf version
CNS Drug Discoveries: What the Future Holds
static version
printer friendly
pdf version
CNS Drug Discoveries: What The Future Holds Sleep Disorders Chapter
static version
printer friendly
pdf version
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study
static version
printer friendly
pdf version
CNS European Market Competitive Strategies - Competitive Analysis, Profiles and Portfolio Strategies of the Top 20 CNS Therapeutic Manufacturers in Europe (2001 Edition)
static version
printer friendly
pdf version
CNS Market Analysis 2002: Commercial Viability of Four Dynamic CNS Markets
static version
printer friendly
pdf version
CNS Market: Year in Review - Sales Overview and Market News, 2000
static version
printer friendly
pdf version
CNS Therapeutics - Global Strategic Business Report
static version
printer friendly
pdf version
CNS Therapy US Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles
static version
printer friendly
pdf version
CNS Therapy Worldwide Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles
static version
printer friendly
pdf version
CNS Year in Review: 2001
static version
printer friendly
pdf version
Commercial Insight: CNS Market Overview - Commercial Dynamics And Outlook Of The Neurology, Pain And Psychiatry Market Sectors
static version
printer friendly
pdf version
Commercial Insight: Epilepsy - Companies Committed to the Cause will Reap the Benefits
static version
printer friendly
pdf version
Commercial Insight: Parkinsons Disease - Increased Focus on Earlier Treatment and Managing Levodopa Complications Will Drive Market Growth
static version
printer friendly
pdf version
Cox-ii Inhibitors: Comparison of Global Markets and Factors Influencing Performance
static version
printer friendly
pdf version
^ Top
D
Disease and Therapy Review: Back Pain
static version
printer friendly
pdf version
Disease and Therapy Review: Epilepsy
static version
printer friendly
pdf version
Disease and Therapy Review: Parkinsons Disease
static version
printer friendly
pdf version
Does the Treatment of Huntingtons Disease Represent a Commercial Opportunity?
static version
printer friendly
pdf version
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
static version
printer friendly
pdf version
Drug Discovery for Nervous System Diseases
static version
printer friendly
pdf version
Drugs in Development for Neurological Disorders, 2003
static version
printer friendly
pdf version
Drugs of Tommorrow 2002: Pain
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Depression - A Future Away From Serotonin?
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class on Acute Treatment Market
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success
static version
printer friendly
pdf version
Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect profile
static version
printer friendly
pdf version
^ Top
E
Emerging Pharmacological Tools in Clinical Neurology
static version
printer friendly
pdf version
Emerging Technologies in Drug Delivery Devices and Implantable Pain Management
static version
printer friendly
pdf version
Epidemiology: Osteo and Rheumatoid Arthritis - Defining the patient populations
static version
printer friendly
pdf version
European Spinal Fusion Products Market, 2005-2011
static version
printer friendly
pdf version
^ Top
G
Glial Neurobiology
static version
printer friendly
pdf version
^ Top
H
Handbook of Psychiatric Drugs
static version
printer friendly
pdf version
Hippocampal Place Fields: Relevance to Learning and Memory
static version
printer friendly
pdf version
^ Top
I
Interferon Current Market Dynamics & Future Outlook
static version
printer friendly
pdf version
^ Top
M
MarketWatch: CNS
static version
printer friendly
pdf version
MarketWatch: CNS
static version
printer friendly
pdf version
MarketWatch: CNS
static version
printer friendly
pdf version
MarketWatch: Insight into Key Events in CNS Industry
static version
printer friendly
pdf version
Marketwatch: Insight Into Key Events In The CNS Industry
static version
printer friendly
pdf version
Multiple Sclerosis: Continued efforts to extend product lifecycles
static version
printer friendly
pdf version
^ Top
N
Neurodegenerative Disease: The Growing Market for Drugs used in the Treatment of Alzheimer's, Parkinson's and other Neurodegenerative Conditions
static version
printer friendly
pdf version
Neurological and Psychiatric Diseases: Pharmacological Treatments and Commercial Outlook in an Aging Population
static version
printer friendly
pdf version
Neurological Monitors Market, 1998-2008
static version
printer friendly
pdf version
Neuroprotection - Drugs, Markets and Companies
static version
printer friendly
pdf version
^ Top
O
Orphan Diseases in the CNS Market
static version
printer friendly
pdf version
^ Top
P
Pain Diagnosis - Issues Impact the Pharmaceutical Industry
static version
printer friendly
pdf version
Pain Therapeutics: A Strategic Re-evaluation.
static version
printer friendly
pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Central Nervous System
static version
printer friendly
pdf version
PharmaWatch: CNS
static version
printer friendly
pdf version
Pipeline and Commercial Insight: Alzheimers Disease - Scenario Forecasts Reveal Vast Market Potential
static version
printer friendly
pdf version
Pipeline and Commercial Insight: Parkinsons Disease - Market to grow as first round of lifecycle management strategies succeed
static version
printer friendly
pdf version
Pipeline Insight: Multiple Sclerosis - The Oral Revolution
static version
printer friendly
pdf version
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntingtons Disease
static version
printer friendly
pdf version
Pipeline Insight: Schizophrenia
static version
printer friendly
pdf version
Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
static version
printer friendly
pdf version
Portfolio Management in CNS: Composite Portfolio Analysis of Eli Lilly and Novartis
static version
printer friendly
pdf version
Pricing and Reimbursement Issues in Neurology
static version
printer friendly
pdf version
^ Top
R
Reward and Decision Making in Corticobasal Ganglia Networks
static version
printer friendly
pdf version
^ Top
S
Severe Dementia
static version
printer friendly
pdf version
Sex Differences in the Brain: From Genes to Behavior
static version
printer friendly
pdf version
Short Protocols in Neuroscience: Systems and Behavioral Method
static version
printer friendly
pdf version
Stakeholder Opinion: Erectile Dysfunction - Identifying Product Differentiation and Patient Segmentation Strategies
static version
printer friendly
pdf version
Stem Cell Therapeutics
static version
printer friendly
pdf version
Strategic Analysis of World Emerging Neurological Therapeutics Markets
static version
printer friendly
pdf version
Strategic Perspective 2001: Opioid Use in Pain Management
static version
printer friendly
pdf version
Strategic Perspectives 2001: Neuropathic pain - Catch 22: high revenue potential but a high risk investment
static version
printer friendly
pdf version
Strategic Perspectives 2002: CNS Disorders in Women - Urinary Incontinence
static version
printer friendly
pdf version
^ Top
T
Target Product Profiles 2008: Physician Insights on Key Attributes - Diabetic Nephropathy
static version
printer friendly
pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Multiple Sclerosis (Chronic-Progressive)
static version
printer friendly
pdf version
The Brain Atlas: A Visual Guide to the Human Central Nervous System, 3rd Edition
static version
printer friendly
pdf version
The CNS Market 2008 Report
static version
printer friendly
pdf version
The CNS Market Outlook to 2010
static version
printer friendly
pdf version
The CNS Market Outlook to 2011
static version
printer friendly
pdf version
The CNS Market Outlook to 2012
static version
printer friendly
pdf version
The CNS Outlook to 2007
static version
printer friendly
pdf version
The Embryonic Human Brain: An Atlas of Developmental Stages, 3rd Edition
static version
printer friendly
pdf version
The MAK Collection for Occupational Health and Safety: Part IV: Biomonitoring Methods, Volume 11
static version
printer friendly
pdf version
The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System
static version
printer friendly
pdf version
The Outlook For Niche CNS Disorders: Commercial Opportunities In Developing Markets
static version
printer friendly
pdf version
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D
static version
printer friendly
pdf version
Therapeutic Clinical Intelligence - Multiple Sclerosis Vol II
static version
printer friendly
pdf version
Therapeutic Clinical Intelligence - Rheumatoid Arthritis
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Alzheimer's Disease
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Anxiety & Depression
static version
printer friendly
pdf version
Top CNS Portfolios in 2004 - The Industry Gold Standards
static version
printer friendly
pdf version
Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite
static version
printer friendly
pdf version
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice
static version
printer friendly
pdf version
Treatment-resistant depression: An untapped area of the patient population
static version
printer friendly
pdf version
Trial TRAX - Multiple Sclerosis - Clinical Trial Monitoring Brief
static version
printer friendly
pdf version
^ Top
U
U.S. Multiple Sclerosis Markets
static version
printer friendly
pdf version
U.S. Neurological Devices Market - Investment Analysis
static version
printer friendly
pdf version
U.S. Sales and Growth for Neurological Monitor SAM, 1998-2008
static version
printer friendly
pdf version
Update:The CNS Outlook 2000
static version
printer friendly
pdf version
^ Top
V
Vagus Nerve Stimulation: The potential impact on pharmacotherapy in epilepsy and mood disorders
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy